GlaxoSmithKline

From Wikicompany

GlaxoSmithKline

Image:Glaxosmithkline.png

[edit]

Contacts

Web:
Email: [mailto:]
Phone: [callto://]
Fax:
Address: ,[[:Category:|]], [[:Category:|]]
Geocode:
[edit]

Info

Feeds: RSSv2.0 feedrss
Sectors:
Products:
Type:
Regions:
Open times:
Founding:
Employees:
Key people:
[edit]

Relations

Parents:
Subsidiaries:
Affiliates:
Partners:
Customers:
Competitors:
[edit]

Web

Links: alexa
Web: google, yahoo
Stock:
Financial: google-finance, yahoo-finance
News: google, yahoo, indymedia
Blogs: technorati, feedster, google
Articles: google, del.icio.us, digg
Photos: google, yahoo, flickr, yotophoto, wikimedia
Audio: feedster, potkast, podscope, podzinger, yahoo, altavista
Video: google, yahoo, youtube
Jobs: monster, indeed,
Products: froogle, google-base, yahoo, become, amazon, ebay

Template:Infobox Company

GlaxoSmithKline (GSK) plc is a pharmaceutical and healthcare company. The second largest pharmaceutical company in the world, in 2004, the company had sales of �20.3 billion and made a profit of �6.1 billion. It employs around 100,000 people worldwide, including over 40,000 in sales and marketing. Its worldwide headquarters is in London, with dual US headquarters in Philadelphia and Research Triangle Park.

The company is listed on the London and New York Stock Exchanges. It does most of its business in the United States, but has a presence in almost 70 countries. The company's CEO is Jean-Pierre Garnier (former COO of SmithKline Beecham) and the non-executive chairman is Sir Christopher Gent.

GSK was formed in December 2000 by a merger between Glaxo Wellcome and SmithKline Beecham, both the product of mergers themselves, as recently as 1995 for Glaxo and Wellcome. GSK was actually incorporated in December 1999 as part of the lengthy merger process. As a result of the mergers, the company has certain minor businesses which are not strictly within its larger interests.

In 2004, pharmaceutical sales accounted for �17 billion of GSK's total sales. Sales are largely based around a small number of successful products, the SSRI Paxil (paroxetine) accounted for �2.1 billion in sales alone.

Other key products include:

The company works hard to protect the patents of its drug formulations and their respective trademarks. It recently went to court to enforce patents on Augmentin (2002) and Paxil (2003), but lost both trials.

At their AGM on 19 May 2003, GSK shareholders rejected a motion regarding a �22 million pay and benefits package for Jean-Pierre Garnier. This is the first time such a rebellion by shareholders against a major British company has occurred, but is regarded as a possible turning point against other so-called "fat cat" deals within executive pay structures.

In June 2004 the company had court proceedings initiated against them on allegations of fraud. The allegation is that the company suppressed research that shows that Paxil/Seroxat is little more effective than a placebo and increases suicidal feelings in young people, side effects which have commonly been reported by users for some time.

[edit]

Diversity

GlaxoSmithKline was named one of the 100 Best Companies for Working Mothers in 2004 by Working Mothers magazine.

[edit]

External links

  • Historical timeline including mergers that led to GlaxoSmithKline
  • GlaxoSmithKline Yahoo! Company Profile
  • Glaxo faces drug fraud lawsuit - The Guardian - June 2004
  • And the medicine cabinet was bare - The Guardian - September 2004
  • Satellite image of the company Headquarters
  • Pharmaceutical Companies Listings
  • Clinical Research Services
  • Clinical Research Training
  • International Clinical Research Services and Corporate Trainings
  • Clinical Research Abbreviations and Acronyms
  • Clinical Research Glossary / Definitions
  • List of Food and Drugs Regulatory Agencies
  • Clinical Research: Frequently asked questionsde:GlaxoSmithKline

ja:グラクソ・スミスクライン no:GlaxoSmithKline zh:葛蘭素史克

News

  • Ranbaxy Buying Generic Business of GlaxoSmithKline's Italy Unit - Bloomberg
  • GlaxoSmithKline Looks To RFID To Protect Patients Against ... - Industry Week
  • Pharmaceutical: GLAXOSMITHKLINE PAKISTAN LIMITED - Year Ended ... - Therapeutics Daily (subscription) (press release)
  • GlaxoSmithKline Tags HIV Drug - RFID Solutions Online (press release)
  • GlaxoSmithKline publishes CR Report 2005 - ReportAlert! - csr-news.net (Pressemitteilung)
  • Novartis: telbivudine better than Epivir - United Press International
  • CV Therapeutics Launches Ranexa and GlaxoSmithKline Applies for ... - Financial News USA (press release)
  • GlaxoSmithKline starts RFID anti-counterfeit tests - UsingRFID.com (subscription)
  • AstraZeneca buyout: A fish story? - The News Journal
  • Editorial | Cervical Cancer Vaccine Give it a fair trial - Centre Daily Times
  • ... more news

Blogs

  • GlaxoSmithKline Submits Biologics License Application For FDA ... (Tennessee Business License)
  • GlaxoSmithKline faces new allergy competitor
  • GlaxoSmithKline gets nod to import bird flu drug
  • GlaxoSmithKline K.K. To Conduct Clinical Study Of HPV Vaccine, Japan
  • GlaxoSmithKline begins testing new technology, press release of 22 march
  • GlaxoSmithKline to Tag HIV Medicine - Houston Chro...
  • AVANT Receives $4 Million Milestone Payment from GlaxoSmithKline
  • Pharmaceutical Sales - Interview with GlaxoSmithKline Pharmaceutical %2ASpecial Interview Session%2A ( Girdwood, AK US )
  • Pharmaceutical Sales - Interview with GlaxoSmithKline Pharmaceutical %2ASpecial Interview Session%2A ( Anchorage, AK US )

Related articles

Image:Wikipedia-small.png Wikipedia article about GlaxoSmithKline (search). This article uses material from that article.
[[Category:]]

[[Category:]] [[Category:]] [[Category:]]

Actions